Adams Labs Taps Former Novartis Exec, CHPA Chair Valentino For CEO Post
This article was originally published in The Tan Sheet
Executive Summary
Newly appointed Adams Labs CEO Michael Valentino's primary task will be to decide whether to model the firm as an OTC player or maintain its focus on Rx specialty pharmaceuticals
You may also be interested in...
Mucinex Line Extensions Underscore Adams’ Commitment To Building OTCs
A major task facing Adams Respiratory Therapeutics' new VP-OTC Marketing & Business Development Robert Casale will be to plan a Fall 2004 launch of extensions to the firm's Mucinex expectorant brand
Mucinex Line Extensions Underscore Adams’ Commitment To Building OTCs
A major task facing Adams Respiratory Therapeutics' new VP-OTC Marketing & Business Development Robert Casale will be to plan a Fall 2004 launch of extensions to the firm's Mucinex expectorant brand
Mucinex Line Extensions Underscore Adams’ Commitment To Building OTCs
A major task facing Adams Respiratory Therapeutics' new VP-OTC Marketing & Business Development Robert Casale will be to plan a Fall 2004 launch of extensions to the firm's Mucinex expectorant brand